These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES Atherosclerosis; 2011 May; 216(1):199-204. PubMed ID: 21315356 [TBL] [Abstract][Full Text] [Related]
14. Microalbuminuria in essential hypertension. Mimran A Clin Exp Hypertens; 1997; 19(5-6):753-67. PubMed ID: 9247753 [TBL] [Abstract][Full Text] [Related]
15. Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients. Tedesco MA; Natale F; Mocerino R; Tassinario G; Calabrò R J Hum Hypertens; 2007 Apr; 21(4):291-6. PubMed ID: 17252030 [TBL] [Abstract][Full Text] [Related]
16. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331 [TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. Ravera M; Ratto E; Vettoretti S; Viazzi F; Leoncini G; Parodi D; Tomolillo C; Del Sette M; Maviglio N; Deferrari G; Pontremoli R J Nephrol; 2002; 15(5):519-24. PubMed ID: 12455718 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression? Redon J Curr Opin Nephrol Hypertens; 2005 Sep; 14(5):448-52. PubMed ID: 16046903 [TBL] [Abstract][Full Text] [Related]